Actinobacillus pleuropneumoniae: pathogenesis, diagnostic, treatment and prophylaxy;Pleuropneumonie à Actinobacillus pleuropneumoniae : pathogénie, diagnostic, traitement et prophylaxie

Annales de Medecine Veterinaire

Volumn 152, Issue 3, 2008, Pages 152-179

  Vanden Bergh, P ^a   Zecchinon, L ^a   Fett, T ^a   Desmecht, D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIAE; MYCOPLASMA; SUS;

EID: 67149103935     PISSN: 00034118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (281)

1. Aarestrup F.M., Jensen N.E. Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests. Vet. Microbiol., 1999, 64, 299-305.
2. Ajito T., Haga Y., Homma S., Goryo M., Okada K. Immunohistological evaluation on respiratory lesions of pigs intranasally inoculated with Actinobacillus pleuropneumoniae serotype 1. J. Vet. Med. Sci., 1996, 58, 297-303.
3. Andresen L.O., Jacobsen M.J., Nielsen J.P. Experimental vaccination of pigs with an Actinobacillus pleuropneumoniae serotype 5b capsular polysaccharide-tetanus toxoid conjugate. Acta Vet. Scand., 1997, 38, 283-293.
4. Andresen L.O., Klausen J., Barfod K., Sorensen V. Detection of antibodies to Actinobacillus pleuropneumoniae serotype 12 in pig serum using a blocking enzyme-linked immunosorbent assay. Vet. Microbiol., 2002, 89, 61-67.
5. Baarsch M.J., Scamurra R.W., Burger K., Foss D.L., Maheswaran S.K., Murtaugh M.P. Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae. Infect. Immun., 1995, 63, 3587- 3594.
6. Babior B.M. The respiratory burst oxidase. Curr. Opin. Hematol., 1995, 2, 55-60.
7. Beck M., Van Den Bosch J.F., Jongenelen I.M., Loeffen P.L., Nielsen R., Nicolet J., frey J. RTX toxin genotypes and phenotypes in Actinobacillus pleuropneumoniae field strains. J. Clin. Microbiol., 1994, 32, 2749- 2754.
8. Bei W., He Q., Yan L., Fang L., Tan Y., Xiao S., Zhou R., Jin M., Guo A., Lv J., Huang H., Chen H. Construction and characterization of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker. FEMS Microbiol. Lett., 2005, 243, 21-27.
9. Bei W., He Q., Zhou R., Yan L., Huang H., Chen H. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs. Vet. Microbiol., 2007, 125, 120-127.
10. Belanger M., Rioux S., Foiry B., Jacques M. Affinity for porcine respiratory tract mucus is found in some isolates of Actinobacillus pleuropneumoniae. FEMS Microbiol. Lett., 1992, 76, 119-125.
11. Belanger M., Dubreuil D., Jacques M. Proteins found within porcine respiratory tract secretions bind lipopolysaccharides of Actinobacillus pleuropneumoniae. Infect. Immun., 1994, 62, 868- 873.
12. Bendixen P.H., Shewen P.E., Rosendal S., Wilkie B.N. Toxicity of Haemophilus pleuropneumoniae for porcine lung macrophages, peripheral blood monocytes, and testicular cells. Infect. Immun., 1981, 33, 673-676.
13. Bertram T.A. Quantitative morphology of peracute pulmonary lesions in swine induced by Haemophilus pleuropneumoniae. Vet. Pathol., 1985, 22, 598-609.
14. Bertram T.A. Intravascular macrophages in lungs of pigs infected with Haemophilus pleuropneumoniae. Vet. Pathol., 1986, 23, 681-691.
15. Bertram T.A. Pathobiology of Acute Pulmonary Lesions in Swine Infected with Haemophilus (Actinobacillus) pleuropneumoniae. Can. Vet. J., 1988, 29, 574-577.
16. Beskow P., Norqvist M., Wallgren P. Relationships between selected climatic factors in fattening units and their influence on the development of respiratory diseases in swine. Acta Vet. Scand., 1998, 39, 49-60.
17. Bilinski T. Oxygen toxicity and microbial evolution. Biosystems, 1991, 24, 305-312.
18. Blackall P.J., Bowles R., Pahoff J.L., Smith B.N. Serological characterisation of Actinobacillus pleuropneumoniae isolated from pigs in 1993 to 1996. Aust. Vet. J., 1999, 77, 39-43.
19. Blanco M., Gutierrez-Martin C.B., Rodriguez-Ferri E.F., Roberts M.C., NAVAS J. Distribution of tetracycline resistance genes in Actinobacillus pleuropneumoniae isolates from Spain. Antimicrob. Agents Chemother., 2006, 50, 702-708.
20. Blanco M., Kadlec K., Gutierrez Martin C.B., De La Fuente A.J., Schwarz S., Navas J. Nucleotide sequence and transfer properties of two novel types of Actinobacillus pleuropneumoniae plasmids carrying the tetracycline resistance gene tet(H). J. Antimicrob. Chemother., 2007, 60, 864-867.
21. Boekema B.K., Stockhofe-zurwieden N., Smith H.E., Kamp E.M., Van Putten J.P., Verheijden J.H. Adherence of Actinobacillus pleuropneumoniae to primary cultures of porcine lung epithelial cells. Vet. Microbiol., 2003, 93, 133-144.
22. Bosse J.T., Johnson R.P., Rosendal S. Serodiagnosis of pleuropneumonia using enzymelinked immunosorbent assay with capsular polysaccharide antigens of Actinobacillus pleuropneumoniae serotypes 1, 2, 5 and 7. Can. J. Vet. Res., 1990, 54, 427-431.
23. Bosse J.T., Friendship R., Rosendal S., Fenwick B.W. Development and evaluation of a mixed-antigen ELISA for serodiagnosis of Actinobacillus pleuropneumoniae serotypes 1, 5, and 7 infections in commercial swine herds. J. Vet. Diagn. Invest., 1993, 5, 359-362.
24. Bosse J.T., Macinnes J.I. Urease activity may contribute to the ability of Actinobacillus pleuropneumoniae to establish infection. Can. J. Vet. Res., 2000, 64, 145-150.
25. Bosse J.T., Janson H., Sheehan B.J., Beddek A.J., Rycroft A.N., Kroll J.S., Langford P.R. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect., 2002, 4, 225- 235.
26. Bousquet E., Morvan H., Aitken I., Morgan J.H. Comparative in vitro activity of doxycycline and oxytetracycline against porcine respiratory pathogens. Vet. Rec., 1997, 141, 37-40.
27. Broes A., Martineau G.-P., Gottschalk M. Dealing with unexpected Actinobacillus pleuropneumoniae serological results. J. Swine Health Prod., 2007, 15, 264-269.
28. Bunka S., Christensen C., Potter A.A., Willson P.J., Gerlach G.F. Cloning and characterization of a protective outer membrane lipoprotein of Actinobacillus pleuropneumoniae serotype 5. Infect. Immun., 1995, 63, 2797-2800.
29. Burdychova R., Rychtera M., Horvath R., Dendis M., Bartos M. Expression of Actinobacillus pleuropneumoniae gene coding for Apx I protein in Escherichia coli. FEMS Microbiol. Lett., 2004, 230, 9-12.
30. Burton P.J., Thornsberry C., Cheung Yee Y., Watts J.L., Yancey R.J., JR. Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease. J. Vet. Diagn. Invest., 1996, 8, 464-468.
31. Buttenschon J., Friis N.F., Aalbaek B., Jensen T.K., Iburg T., Mousing J. Microbiology and pathology of fibrinous pericarditis in Danish slaughter pigs. Zentralbl. Veterinarmed. A, 1997, 44, 271- 280.
32. Chang C.F., Chang L.C., Chang Y.F., Chen M., Chiang T.S. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis recovered from Taiwanese swine. J. Vet. Diagn. Invest., 2002a, 14, 153-157.
33. Chang C.F., Yeh T.M., Chou C.C., Chang Y.F., Chiang T.S. Antimicrobial susceptibility and plasmid analysis of Actinobacillus pleuropneumoniae isolated in Taiwan. Vet. Microbiol., 2002b, 84, 169-177.
34. Chang S.W., Westcott J.Y., Pickett W.C., Murphy R.C., Voelkel N.F. Endotoxin-induced lung injury in rats: role of eicosanoids. J. Appl. Physiol., 1989, 66, 2407-2418.
35. Chang Y.F., Shi J., Shin S.J., Lein D.H. Sequence analysis of the ROB-1 beta-lactamase gene from Actinobacillus pleuropneumoniae. Vet. Microbiol., 1992, 32, 319-325.
36. Chen S.D. Characterization of polymorphic mononuclear cell in porcine Actinobacillus pleuropneumonia. Proc. Natl. Sci. Counc. Repub. China B, 1997, 21, 1-7.
37. Chiers K., Haesebrouck F., Van Overbeke I., Charlier G., Ducatelle R. Early in vivo interactions of Actinobacillus pleuropneumoniae with tonsils of pigs. Vet. Microbiol., 1999, 68, 301-306.
38. Chiers K., Van Overbeke I., Donne E., Baele M., Ducatelle R., De Baere T., Haesebrouck F. Detection of Actinobacillus pleuropneumoniae in cultures from nasal and tonsillar swabs of pigs by a PCR assay based on the nucleotide sequence of a dsbE-like gene. Vet. Microbiol., 2001, 83, 147-159.
39. Cho W.S., Chae C. Expression of the apxIV gene in pigs naturally infected with Actinobacillus pleuropneumoniae. J. Comp. Pathol., 2001, 125, 34-40.
40. Cho W.S., Choi C., Chae C. In situ hybridization for the detection of the apxIV gene in the lungs of pigs experimentally infected with twelve Actinobacillus pleuropneumoniae serotypes. Vet. Res., 2002, 33, 653-660.
41. Cho W.S., Chae C. Expression of nitric oxide synthase 2 and tumor necrosis factor alpha in swine naturally infected with Actinobacillus pleuropneumoniae. Vet. Pathol., 2002a, 39, 27-32.
42. Cho W. S., Chae C. Immunohistochemical detection and distribution of inducible nitric oxide synthase in pigs naturally infected with Actinobacillus pleuropneumoniae. J. Comp. Pathol., 2002b, 126, 109-114.
43. Cho W.S., Chae C. In vitro effects of Actinobacillus pleuropneumoniae on inducible nitric oxide synthase and cyclooxygenase-2 in porcine alveolar macrophages. Am. J. Vet. Res., 2003a, 64, 1514-1518.
44. Cho W.S., Chae C. Evidence of nitric oxide synthase 2 activity in swine naturally infected with Actinobacillus pleuropneumoniae. Vet. Pathol., 2003b, 40, 276-282.
45. Cho W.S., Chae C. Differentiation of twelve Actinobacillus pleuropneumoniae serotypes by outer membrane lipoprotein gene-based restriction fragment length polymorphism. J. Vet. Med. B Infect. Dis. Vet. Public Health, 2003c, 50, 90-94.
46. Cho W.S., Chae C. Expression of cyclooxygenase-2 i n swine naturally infected with Actinobacillus pleuropneumoniae. Vet. Pathol., 2003d, 40, 25-31.
47. Cho W.S., Chae C. Expression of nitric oxide synthase 2 and cyclooxygenase-2 in swine experimentally infected with Actinobacillus pleuropneumoniae. Vet. Pathol., 2004a, 41, 666-672.
48. Cho W.S., Chae C. Detection of nuclear factor-kappaB and inducible nitric oxide synthase in the lungs of pigs naturally infected with Actinobacillus pleuropneumoniae. J. Comp. Pathol., 2004b, 130, 112-116.
49. Choi C., Kwon D., Min K., Chae C. In-situ hybridization for the detection of inflammatory cytokines (IL-1, TNF-alpha and IL-6) in pigs naturally infected with Actinobacillus pleuropneumoniae. J. Comp. Pathol., 1999, 121, 349-356.
50. Choi C., Kwon D., Min K., Chae C. Detection and localization of ApxI, -II and -III genes of Actinobacillus pleuropneumoniae in natural porcine pleuropneumonia in natural porcine pleuropneumonia by in situ hybridization. Vet. Pathol., 2001, 38, 390-395.
51. Crow J.P., Beckman J.S. Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv. Pharmacol., 1995, 34, 17-43.
52. Cruijsen T., Van Leengoed L.A., Ham-Hoffies M., Verheijden J.H. Convalescent pigs are protected completely against infection with a homologous Actinobacillus pleuropneumoniae strain but incompletely against a heterologous-serotype strain. Infect. Immun., 1995, 63, 2341- 2343.
53. Cruijsen T.L., Van Leengoed L.A., Dekker-Nooren T.C., Schoevers E.J., Verheijden J.H. Phagocytosis and killing of Actinobacillus pleurpneumoniae by alveolar macrophages and polymorphonuclear leukocytes isolated from pigs. Infect. Immun., 1992, 60, 4867-4871.
54. Cullen J.M., Rycroft A.N. Phagocytosis by pig alveolar macrophages of Actinobacillus pleuropneumoniae serotype 2 mutant strains defective in haemolysin II (ApxII) and pleurotoxin (ApxIII). Microbiology, 1994, 140, 237- 244.
55. Da Costa M.M., Klein C.S., Balestrin R., Schrank A., Piffer I.A., Da Silva S.C., Schrank I.S. Evaluation of PCR based on gene apxIVA associated with 16S rDNA sequencing for the identification of Actinobacillus pleuropneumoniae and related species. Curr. Microbiol., 2004, 48, 189-195.
56. De La Puente-Redondo V.A., Del Blanco N.G., Gutierrez-Martin C.B., Mendez J.N., Rodriquez Ferri E.F. Detection and subtyping of Actinobacillus pleuropneumoniae strains by PCR-RFLP analysis of the tbpA and tbpB genes. Res. Microbiol., 2000, 151, 669-681.
57. Devenish J., Rosendal S., Bosse J.T. Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae. Infect. Immun., 1990, 58, 3829-3832.
58. Dom P., Haesebrouck F., De Baetselier P. Stimulation and suppression of the oxygenation activity of porcine pulmonary alveolar macrophages by Actinobacillus pleuropneumoniae and its metabolites. Am. J. Vet. Res., 1992a, 53, 1113-1118.
59. Dom P., Haesebrouck F., Kamp E.M., Smits M.A. Influence of Actinobacillus pleuropneumoniae serotype 2 and its cytolysins on porcine neutrophil chemiluminescence. Infect. Immun., 1992b, 60, 4328-4334.
60. Dom P., Haesebrouck F. Comparative virulence of NAD-dependent and NAD-independent Actinobacillus pleuropneumoniae strains. Zentralbl. Veterinarmed. B, 1992, 39, 303-306.
61. Dom P., Haesebrouck F., Ducatelle R., Charlier G. In vivo association of Actinobacillus pleuropneumoniae serotype 2 with the respiratory epithelium of pigs. Infect. Immun., 1994a, 62, 1262-1267.
62. Dom P., Haesebrouck F., Kamp E.M., Smits M.A. NAD-independent Actinobacillus pleuropneumoniae strains: production of RTX toxins and interactions with porcine phagocytes. Vet. Microbiol., 1994b, 39, 205-218.
63. Dom P., Hommez J., Castryck F., Devriese L.A., Haesebrouck F. Serotyping and quantitative determination of in vitro antibiotic susceptibility of Actinobacillus pleuropneumoniae strains isolated in Belgium (July 1991-August 1992). Vet. Q., 1994c, 16, 10-13.
64. Dreyfus A., Schaller A., Nivollet S., Segers R.P., Kobisch M., Mieli L., Soerensen V., Hussy D., Miserez R., Zimmermann W., Inderbitzin F., Frey J. Use of recombinant ApxIV in serodiagnosis of Actinobacillus pleuropneumoniae infections, development and prevalidation of the ApxIV ELISA. Vet. Microbiol., 2004, 99, 227-238.
65. Dubreuil J.D., Letellier A., Stenbaek E., Gottschalk M. Serotyping of Actinobacillus pleuropneumoniae serotype 5 strains using a monoclonal-based polystyrene agglutination test. Can. J. Vet. Res., 1996, 60, 69-71.
66. Dubreuil J.D., Jacques M., Mittal K.R., Gottschalk M. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity. Anim. Health Res. Rev., 2000, 1, 73-93.
67. Duff J.P., Scott W.A., Wilkes M.K., Hunt B. Otitis in a weaned pig: a new pathological role for Actinobacillus (Haemophilus) pleuropneumoniae. Vet. Rec., 1996, 139, 561-563.
68. Euzéby J.P. Actinobacillus pleuropneumoniae. [en ligne] (07/06/1998) Adresse URL: http://www.bacterio.cict.fr/bacdico/aa/pleuropneumoniae.html, consulté le 01/12/2007.
69. Fales W.H., Morehouse L.G., Mittal K.R., Beanknudsen C., Nelson S.L., Kintner L.D., Turk J.R., Turk M.A., Brown T.P., Shaw D.P. Antimicrobial susceptibility and serotypes of Actinobacillus (Haemophilus) pleuropneumoniae recovered from Missouri swine. J. Vet. Diagn. Invest., 1989, 1, 16-19.
70. Fenwick B. Actinobacillus pleuropneumoniae. [en ligne] Adresse URL : http://microgen.ouhsc.edu/a_pleuro/a_pleuro_home.htm, consulté le 15/05/2008.
71. Fittipaldi N., Klopfenstein C., Gottschalk M., Broes A., Paradis M.A., Dick C.P. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs. Can. J. Vet. Res., 2005, 69, 146-150.
72. Frey J., Perrin J., Nicolet J. Cloning and expression of a cohemolysin, the CAMP factor of Actinobacillus pleuropneumoniae. Infect. Immun., 1989, 57, 2050- 2056.
73. Frey J., Bosse J.T., Chang Y.F., Cullen J.M., Fenwick B., Gerlach G.F., Gygi D., Haesebrouck F., Inzana T.J., Jansen R., et al. Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes. J. Gen. Microbiol., 1993, 139, 1723-1728.
74. Frey J., Kuhn R., Nicolet J. Association of the CAMP phenomenon in Actinobacillus pleuropneumoniae with the RTX toxins ApxI, ApxII and ApxIII. FEMS Microbiol. Lett., 1994, 124, 245-251.
75. Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol., 1995, 3, 257-261.
76. Fukuyasu T., Saito K., Ashida K. Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs with pneumonia. J. Jpn Vet. Med. Assoc., 1996, 49, 528-532.
77. Fuller T.E., Martin S., Teel J.F., Alaniz G.R., Kennedy M.J., Lowery D.E. Identification of Actinobacillus pleuropneumoniae virulence genes using signature-tagged mutagenesis in a swine infection model. Microb. Pathog., 2000, 29, 39-51.
78. Gagne A., Lacouture S., Broes A., D'allaire S., Gottschalk M. Development of an immunomagnetic method for selective isolation of Actinobacillus pleuropneumoniae serotype 1 from tonsils. J. Clin. Microbiol., 1998, 36, 251-254.
79. Gerlach G.F., Anderson C., Klashinsky S., Rossicampos A., Potter A.A., Willson P.J. Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1. Infect. Immun., 1993, 61, 565- 572.
80. Gilbride K.A., Rosendal S. Evaluation of a selective medium for isolation of Haemophilus pleuropneumoniae. Can. J. Comp. Med., 1983, 47, 445-450.
81. Goethe R., Gonzales O.F., Lindner T., Gerlach G.F. A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction. Vaccine, 2000, 19, 966-975.
82. Goldblum S.E., Hennig B., Jay M., Yoneda K., McClain C.J. Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury. Infect. Immun., 1989, 57, 1218-1226.
83. Gottschalk M., De Lasalle F., Radacovici S., Dubreuil J.D. Evaluation of long chain lipopolysaccharides (LC-LPS) of Actinobacillus pleuropneumoniae serotype 5 for the serodiagnosis of swine pleuropneumonia. Vet. Microbiol., 1994, 38, 315-327.
84. Gottschalk M., Morvan H., Broes A., Desrosiers R., Kobisch M. Actualités sur la pleuropneumonie porcine. Journées Recherche Porcine, 2005, 37, 341-346.
85. Gottschalk M., Taylor D.J. Actinobacillus pleuropneumoniae. In : Straw B.E., Zimmerman J.J., D'Allaire S., Taylor D.J. (Eds), Diseases of swine. 9th ed. Blackwell: Ames, 2006, 563-576.
86. Gram T., Ahrens P. Improved diagnostic PCR assay for Actinobacillus pleuropneumoniae based on the nucleotide sequence of an outer membrane lipoprotein. J. Clin. Microbiol., 1998, 36, 443-448.
87. Gram T., Ahrens P., Andreasen M., Nielsen J.P. An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes--evaluation of isolates from lungs and tonsils of pigs. Vet. Microbiol., 2000, 75, 43-57.
88. Grondahl-Hansen J., Barfod K., Klausen J., Andresen L.O., Heegaard P.M., Sorensen V. Development and evaluation of a mixed long-chain lipopolysaccharide based ELISA for serological surveillance of infection with Actinobacillus pleuropneumoniae serotypes 2, 6 and 12 in pig herds. Vet. Microbiol., 2003, 96, 41-51.
89. Gunnarsson A., Biberstein E.L., Hurvell B. Serologic studies on porcine strains of Haemophilus parahaemolyticus (pleuropneumoniae): agglutination reactions. Am. J. Vet. Res., 1977, 38, 1111-1114.
90. Gutierrez C.B., Rodriguez Barbosa J.I., Tascon R.I., Costa L., Riera P., Rodriguez Ferri E.F. Serological characterisation and antimicrobial susceptibility of Actinobacillus pleuropneumoniae strains isolated from pigs in Spain. Vet. Rec., 1995, 137, 62-64.
91. Gutierrez-Martin C.B., Rodriguez-Delgado O., Alvarez-Nistal D., De La Puente-Redondo V.A., Garcia-Rioja F., Martin-vicente J., Rodriguez Ferri E.F. Simultaneous serological evidence of Actinobacillus pleuropneumoniae, PRRS, Aujeszky's disease and influenza viruses in Spanish finishing pigs. Res. Vet. Sci., 2000, 68, 9-13.
92. Gutierrez-Martin C.B., Del Blanco N.G., Blanco M., Navas J., Rodriguez-Ferri E.F. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade. Vet. Microbiol., 2006, 115, 218-222.
93. Haga Y., Ogino S., Ohashi S., Ajito T., Hashimoto K., Sawada T. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia. J. Vet. Med. Sci., 1997, 59, 115-120.
94. Hamer-Barrera R., Godinez D., Enriquez V.I., Vacapacheco S., Martinez-zuniga R., Talamas-rohana P., Suarez-guemez F., De La Garza M. Adherence of Actinobacillus pleuropneumoniae serotype 1 to swine buccal epithelial cells involves fibronectin. Can. J. Vet. Res., 2004, 68, 33-41.
95. Hart P.H., Ahern M.J., Smith M.D., Finlay-Jones J.J. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology, 1995a, 84, 536-542.
96. Hart P.H., Jones C.A., Finlay-jones J.J. Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J. Leukoc. Biol., 1995b, 57, 909-918.
97. Heegaard P.M., Klausen J., Nielsen J.P., Gonzalez-ramon N., Pineiro M., Lampreave F., Alava M.A. The porcine acute phase response to infection with Actinobacillus pleuropneumoniae. Haptoglobin, C-reactive protein, major acute phase protein and serum amyloid A protein are sensitive indicators of infection. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 1998, 119, 365-373.
98. Hege R., Zimmermann W., Scheidegger R., Stark K.D. Incidence of reinfections with Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae in pig farms located in respiratory-disease-free regions of Switzerland: identification and quantification of risk factors. Acta Vet. Scand., 2002, 43, 145-156.
99. Hensel A., Huter V., Katinger A., Raza P., Strnistschie C., Roesler U., Brand E., Lubitz W. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine, 2000, 18, 2945-2955.
100. Hernanz Moral C., Cascon Soriano A., Sanchez Salazar M., Yugueros Marcos J., Suarez Ramos S., Naharro Carrasco G. Molecular cloning and sequencing of the aroA gene from Actinobacillus pleuropneumoniae and its use in a PCR assay for rapid identification. J. Clin. Microbiol., 1999, 37, 1575-1578.
101. Herradora L.M., Martine-zgamba R. Effect of oral enrofloxacin and florfenicol on pigs experimentally infected with Actinobacillus pleuropneumoniae serotype 1. J. Vet. Med. A Physiol. Pathol. Clin. Med., 2003, 50, 259-263.
102. Hoffman L.J. Actinobacillus (Haemophilus) pleuropneumoniae: use of coagglutination and complement fixation to determine the relationship between presence of organism and antibody titer in slaughterhouse pigs. J. Vet. Diagn. Invest., 1989, 1, 12-15.
103. Hommez J., Devriese L.A., Castryck F., Cassimon P. Slide precipitation: a simple method to type Actinobacillus (Haemophilus) pleuropneumoniae. Vet. Microbiol., 1990, 24, 123-126.
104. Huang H., Potter A.A., Campos M., Leighton F.A., Willson P.J., Haines D.M., Yates W.D. Pathogenesis of porcine Actinobacillus pleuropneumonia, part II: roles of proinflammatory cytokines. Can. J. Vet. Res., 1999, 63, 69-78.
105. Huang H., Zhou R., Fan H., Dan H., Chen M., Yan L., Bei W., Chen H. Generation of monoclonal antibodies and epitope mapping of ApxIVA of Actinobacillus pleuropneumoniae. Mol. Immunol., 2006, 43, 2130-2134.
106. Huie R.E., Padmaja S. The reaction of no with superoxide. Free Radic. Res. Commun., 1993, 18, 195-199.
107. Hulten C., Johansson E., Fossum C., Wallgren P. Interleukin 6, serum amyloid A and haptoglobin as markers of treatment eff icacy in pigs experimentally infected with Actinobacillus pleuropneumoniae. Vet. Microbiol., 2003, 95, 75-89.
108. Hunneman W.A., Pijpers A., Lommerse J., Crauwels A.P., Verheijden J.H. Prophylaxis of pleuropneumonia in pigs by in-feed medication with oxytetracycline and the subsequent transmission of infection. Vet. Rec., 1994, 134, 215-218.
109. Hussy D., Schlatter Y., Miserez R., Inzana T., Frey J. PCR-based identification of serotype 2 isolates of Actinobacillus pleuropneumoniae biovars I and II. Vet. Microbiol., 2004, 99, 307-310.
110. Huter V., Hensel A., Brand E., Lubitz W. Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine. J. Biotechnol., 2000, 83, 161-172.
111. Idris U.E., Harmon B.G., Udeze F.A., Kadis S. Pulmonary lesions in mice inoculated with Actinobacillus pleuropneumoniae hemolysin and lipopolysaccharide. Vet. Pathol., 1993, 30, 234-241.
112. Intervet/Schering Plough Animal Health Porcine pleuropneumonia. (sans date) [en ligne] Adresse URL: http://www.respig.com/diseases/app.asp, consulté le 15/05/2008.
113. Inzana T.J., Ma J., Workman T., Gogolewski R.P., Anderson P. Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5. Infect. Immun., 1988, 56, 1880- 1889.
114. Inzana T.J., Todd J., Veit H.P. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines. Infect. Immun., 1993, 61, 1682-1686.
115. Inzana T.J., Fenwick B. Serologic detection of Actinobacillus pleuropneumoniae in swine by capsular polysaccharide-biotinstreptavidin enzyme-linked immunosorbent assay. J. Clin. Microbiol., 2001, 39, 1279-1282.
116. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys., 1992, 298, 431-437.
117. Ito H., Ishii H., Akiba M. Analysis of the complete nucleotide sequence of an Actinobacillus pleuropneumoniae streptomycin-sulfonamide resistance plasmid, pMS260. Plasmid, 2004, 51, 41-47.
118. Jacobsen M.J., Nielsen J.P. Development and evaluation of a selective and indicative medium for isolation of Actinobacillus pleuropneumoniae from tonsils. Vet. Microbiol., 1995, 47, 191- 197.
119. Jacques M., Foiry B., Higgins R., Mittal K.R. Electron microscopic examination of capsular material from various serotypes of Actinobacillus pleuropneumoniae. J. Bacteriol., 1988, 170, 3314-3318.
120. Jacques M., Belanger M., Roy G., Foiry B. Adherence of Actinobacillus pleuropneumoniae to porcine tracheal epithelial cells and frozen lung sections. Vet. Microbiol., 1991, 27, 133-143.
121. Jacques M., Labrie J., St Michael F., Cox A.D., Paradis M.A., Dick C.P., Klopfenstein C., Broes A., Fittipaldi N., Gottschalk M. Isolation of an atypical strain of Actinobacillus pleuropneumoniae serotype 1 with a truncated lipopolysaccharide outer core and no O-antigen. J. Clin. Microbiol., 2005, 43, 3522-3525.
122. Jaglic Z., Svastova P., Rychlik I., Nedbalcova K., Kucerova Z., Pavlik I., Bartos M. Differentiation of Actinobacillus pleuropneumoniae by PCR-REA based on sequence variability of the apxIVA gene and by ribotyping. Vet. Microbiol., 2004, 103, 63-69.
123. Jansen R., Briaire J., Kamp E.M., Gielkens A.L., Smits M.A. The CAMP effect of Actinobacillus pleuropneumoniae is caused by Apx toxins. FEMS Microbiol. Lett., 1995, 126, 139-143.
124. Jensen A.E., Bertram T.A. Morphological and biochemical comparison of virulent and avirulent isolates of Haemophilus pleuropneumoniae serotype 5. Infect. Immun., 1986, 51, 419- 424.
125. Jensen T.K., Boye M., Hagedorn-Olsen T., Riising H.J., Angen O. Actinobacillus pleuropneumoniae osteomyelitis in pigs demonstrated by fluorescent in situ hybridization. Vet. Pathol., 1999, 36, 258-261.
126. Jessing S.G., Angen O., Inzana T.J. Evaluation of a multiplex PCR test for simultaneous identification and serotyping of Actinobacillus pleuropneumoniae serotypes 2, 5, and 6. J. Clin. Microbiol., 2003, 41, 4095-4100.
127. Jobert J.L., Savoye C., Cariolet R., Kobisch M., Madec F. Experimental aerosol transmission of Actinobacillus pleuropneumoniae to pigs. Can. J. Vet. Res., 2000, 64, 21-26.
128. Jolie R.A., Mulks M.H., Thacker B.J. Antigenic differences within Actinobacillus pleuropneumoniae serotype 1. Vet. Microbiol., 1994, 38, 329-349.
129. Juteau J.M., Sirois M., Medeiros A.A., Levesque R.C. Molecular distribution of ROB-1 beta-lactamase in Actinobacillus pleuropneumoniae. Antimicrob. Agents Chemother., 1991, 35, 1397-1402.
130. Kamp E.M., Popma J.K., Van Leengoed L.A. Serotyping of Haemophilus pleuropneumoniae in the Netherlands: with emphasis on heterogeneity within serotype 1 and (proposed) serotype 9. Vet. Microbiol., 1987, 13, 249-257.
131. Katinger A., Lubitz W., Szostak M.P., Stadler M., Klein R., Indra A., Huter V., Hensel A. Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses. J. Biotechnol., 1999, 73, 251-260.
132. Kawahara K., Kawase H., Nakai T., Kume K., Danbara H. Drug resistance plasmids of Actinobacillus (Haemophilus) pleuropneumoniae serotype 2 strains isolated from swine. Kitasato Arch. Exp. Med., 1990, 63, 131-136.
133. Keystone E., Wherry J., Grint P. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum. Dis. Clin. North Am., 1998, 24, 629-639.
134. Kim T.J., Kim K.H., Lee J.I. Stimulation of mucosal and systemic antibody responses against recombinant transferrinbinding protein B of Actinobacillus pleuropneumoniae with chitosan after tracheal administration in piglets. J. Vet. Med. Sci., 2007, 69, 535-539.
135. Kiorpes A.L., Macwilliams P.S., Schenkman D.I., Backstrom L.R. Blood gas and hematological changes in experimental peracute porcine pleuropneumonia. Can. J. Vet. Res., 1990, 54, 164-169.
136. Klausen J., Andresen L.O., Barfod K., Sorensen V. Blocking enzyme-linked immunosorbent assay for detection of antibodies against Actinobacillus pleuropneumoniae serotype 6 in pig serum. Vet. Microbiol., 2001, 79, 11-18.
137. Klausen J., Andresen L.O., Barfod K., Sorensen V. Evaluation of an enzymelinked immunosorbent assay for serological surveillance of infection with Actinobacillus pleuropneumoniae serotype 5 in pig herds. Vet. Microbiol., 2002, 88, 223-232.
138. Klausen J., Ekeroth L., Grondahl-Hansen J., Andresen L.O. An indirect enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serovar 7 in pig serum. J. Vet. Diagn. Invest., 2007, 19, 244- 249.
139. Klein C.S., Piffer I.A., Ceroni DA Silva S., Schrank A., Favero M.B., Schrank I.S. Detection of Actinobacillus pleuropneumoniae by PCR on field strains from healthy and diseased pigs. Curr. Microbiol., 2003, 46, 443-447.
140. Komal J.P., Mittal K.R. Grouping of Actinobacillus pleuropneumoniae strains of serotypes 1 through 12 on the basis of their virulence in mice. Vet. Microbiol., 1990, 25, 229- 240.
141. Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulos H., Beckman J.S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol., 1992, 5, 834-842.
142. Koyama T., TO H., Nagai S. Isolation of Actinobacillus pleuropneumoniae serovar 15-like strain from a field case of porcine pleuropneumonia in Japan. J. Vet. Med. Sci., 2007, 69, 961-964.
143. Krejci J., Nechvatalova K., Kudlackova H., Faldyna M., Kucerova Z., Toman M. Systemic and local antibody responses after experimental infection with Actinobacillus pleuropneumoniae in piglets with passive or active immunity. J. Vet. Med. B Infect. Dis. Vet. Public Health, 2005, 52, 190-196.
144. Kucerova Z., Jagli C Z., Ondriasova R., Nedbalcova K. Serotype distribution of Actinobacillus pleuropneumoniae isolated from porcine pleuropneumonia in the Czech Republic during period 2003-2004. Vet. Med., 2005, 50, 355-360.
145. Langford P.R., Loynds B.M., Kroll J.S. Cloning and molecular characterization of Cu,Zn superoxide dismutase from Actinobacillus pleuropneumoniae. Infect. Immun., 1996, 64, 5035- 5041.
146. Lauritzen B., Lykkesfeldt J., Skaanild M.T., Angen O., Nielsen J.P., Friis C. Putative biomarkers for evaluating antibiotic treatment: an experimental model of porcine Actinobacillus pleuropneumoniae infection. Res. Vet. Sci., 2003, 74, 261-270.
147. Lauweryns J.M., Baert J.H. Alveolar clearance and the role of the pulmonary lymphatics. Am. Rev. Respir. Dis., 1977, 115, 625- 683.
148. Lebrun A., Lacouture S., Cote D., Mittal K.R., Gottschalk M. Identification of Actinobacillus pleuropneumoniae strains of serotypes 7 and 4 using monoclonal antibodies: demonstration of common LPS O-chain epitopes with Actinobacillus lignieresii. Vet. Microbiol., 1999, 65, 271- 282.
149. Lechtenberg K.F., Shryock T.R., Moore G. Characterization of an Actinobacillus pleuropneumoniae seeder pig challenge-exposure model. Am. J. Vet. Res., 1994, 55, 1703-1709.
150. Lee K.Y., Kim D.H., Kang T.J., Kim J., Chung G.H., Yoo H.S., Arntzen C.J., Yang M.S., Jang Y.S. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol. Med. Microbiol., 2006, 48, 381-389.
151. Leiner G., Franz B., Strutzberg K., Gerlach G.F. A novel enzyme-linked immunosorbent assay using the recombinant Actinobacillus pleuropneumoniae ApxII antigen for diagnosis of pleuropneumonia in pig herds. Clin. Diagn. Lab. Immunol., 1999, 6, 630-632.
152. Li S.Q., Yi J.P., Chen Z.F., Wang Q.Q., Zhou X.H., Luo M.L., Fang Y., Chen M., Xia Q. [Development and application of multiplex-PCR for identification of Actinobacillus pleuropneumoniae]. Wei Sheng Wu Xue Bao, 2005, 45, 966-969.
153. Liao C.W., Chiou H.Y., Yeh K.S., Chen J.R., Weng C.N. Oral immunization using formalin-inactivated Actinobaci llus pleuropneumoniae antigens entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process. Prev. Vet. Med., 2003, 61, 1-15.
154. Liggett A.D., Harrison L.R., Farrell R.L. Sequential study of lesion development in experimental Haemophilus pleuropneumonia. Res. Vet. Sci., 1987, 42, 204-212.
155. Lin G., Pearson A.E., Scamurra R.W., Zhou Y., Baarsch M.J., Weiss D.J., Murtaugh M.P. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J. Biol. Chem., 1994, 269, 77-85.
156. Lin L., Bei W., Sha Y., Liu J., Guo Y., Liu W., Tu S., He Q., Chen H. Construction and immunogencity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1. FEMS Microbiol. Lett., 2007, 274, 55-62.
157. Liu J., Chen X., Lin L., Tan C., Chen Y., Guo Y., Jin M., Guo A., Bei W., Chen H. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine, 2007, 25, 7696-7705.
158. Loeffen W.L., Kamp E.M., Stockhofe-Zurwieden N., Van Nieuwstadt A.P., Bongers J.H., Hunneman W.A., Elbers A.R., Baars J., Nell T., Van Zijderveld F.G. Survey of infectious agents involved in acute respiratory disease in finishing pigs. Vet. Rec., 1999, 145, 123-129.
159. Lombin L.H., Rosendal S., Mitchell W.R. Evaluation of the complement fixation test for the diagnosis of pleuropneumonia of swine caused by Haemophilus pleuropneumoniae. Can. J. Comp. Med., 1982, 46, 109-114.
160. Losinger W.C. Economic impacts of reduced pork production associated with the diagnosis of Actinobacillus pleuropneumoniae on grower/finisher swine operations in the United States. Prev. Vet. Med., 2005, 68, 181-193.
161. Luque I., Tarradas C., Carrasco L., Torroella E., Artigas C., Perea A. Effectiveness of doxycycline in the prevention of an experimental infection with Actinobacillus pleuropneumoniae in pigs. J. Vet. Med. B Infect. Dis. Vet. Public Health, 2000, 47, 445-451.
162. Ma J.N., Inzana T.J. Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae. J. Clin. Microbiol., 1990, 28, 1356-1361.
163. Maas A., Meens J., Baltes N., Hennig-Pauka I., Gerlach G.F. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection. Vaccine, 2006a, 24, 7226-7237.
164. Maas A., Jacobsen I.D., Meens J., Gerlach G.F. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals. Infect. Immun., 2006b, 74, 4124- 4132.
165. Macfadyen L.P., Redfield R.J. Life in mucus: sugar metabolism in Haemophilus influenzae. Res. Microbiol., 1996, 147, 541-551.
166. Madsen L.W., Boye M., Jensen T.K., Svensmark B. Actinobacillus pleuropneumoniae demonstrated in situ in exudative meningitis and nephritis. Vet. Rec., 2001, 149, 746-747.
167. Maes D., Chiers K., Haesebrouck F., Laevens H., Verdonck M., De Kruif A. Herd factors associated with the seroprevalences of Actinobacillus pleuropneumoniae serovars 2, 3 and 9 in slaughter pigs from farrow-to-finish pig herds. Vet. Res., 2001, 32, 409-419.
168. Maes D.G., Chiers K., Haesebrouck F., Laevens H., Verdonck M., De Kruif A. Seroprevalence of Actinobacillus pleuropneumoniae serovars 2, 3 and 9 in slaughter pigs from Belgian fattening farms. Vet. Rec., 2002, 151, 206-210.
169. Matter D., Rossano A., Limat S., Vorlet-Fawer L., Brodard I., Perreten V. Antimicrobial resistance profile of Actinobacillus pleuropneumoniae and Actinobacillus porcitonsillarum. Vet. Microbiol., 2007, 122, 146-156.
170. McDowell S.W., Ball H.J. Serotypes of Actinobacillus pleuropneumoniae isolated in the British Isles. Vet. Rec., 1994, 134, 522-523.
171. Mei L., Zhou R., Lu H.S., Bei W.C., Liu W.H., Lin L.W., Hong W.Z., Chen H.C. [Study on immunogenicity of the N-terminal polypeptide of RTX toxin I of Actinobacillus pleuropneumoniae]. Sheng Wu Gong Cheng Xue Bao, 2006, 22, 39-45.
172. Mengelers M.J., Kuiper H.A., Pijpers A., Verheijden J.H., Van Miert A.S. Prevention of pleuropneumonia in pigs by in-feed medication with sulphadimethoxine and sulphamethoxazole in combination with trimethoprim. Vet. Q., 2000, 22, 157-162.
173. Min K., Chae C. Serotype and apx genotype profiles of Actinobacillus pleuropneumoniae field isolates in Korea. Vet. Rec., 1999, 145, 251-254.
174. Mittal K.R., Higgins R., Lariviere S. Evaluation of slide agglutination and ring precipitation tests for capsular serotyping of Haemophilus pleuropneumoniae. J. Clin. Microbiol., 1982, 15, 1019-1023.
175. Mittal K.R., Higgins R., Lariviere S. Detection of type-specific antigens in the lungs of Haemophilus pleuropneumoniae-infected pigs by coagglutination test. J. Clin. Microbiol., 1983a, 18, 1355-1357.
176. Mittal K.R., Higgins R., Lariviere S. Identification and serotyping of Haemophilus pleuropneumoniae by coagglutination test. J. Clin. Microbiol., 1983b, 18, 1351-1354.
177. Mittal K.R., Higgins R., Lariviere S. Determination of antigenic specificity and relationship among Haemophilus pleuropneumoniae serotypes by an indirect hemagglutination test. J. Clin. Microbiol., 1983c, 17, 787-790.
178. Mittal K.R., Higgins R., Lariviere S., Nadeau M. Serological characterization of Actinobacillus pleuropneumoniae strains isolated from pigs in Quebec. Vet. Microbiol., 1992, 32, 135-148.
179. Mittal K.R., Bourdon S., Berrouard M. Evaluation of counterimmunoelectrophoresis for serotyping Actinobacillus pleuropneumoniae isolates and detection of type-specific antigens in lungs of infected pigs. J. Clin. Microbiol., 1993a, 31, 2339- 2342.
180. Mittal K.R., Kamp E.M., Kobisch M. Serological characterisation of Actinobacillus pleuropneumoniae strains of serotypes 1, 9 and 11. Res. Vet. Sci., 1993b, 55, 179-184.
181. Moller K., Andersen L.V., Christensen G., Kilian M. Optimalization of the detection of NAD dependent Pasteurellaceae from the respiratory tract of slaughterhouse pigs. Vet. Microbiol., 1993, 36, 261-271.
182. Moore G.M., Mowrey D.H., Tonkinson L.V., L echt enberg K. F., Schneider J.H. Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine. Am. J. Vet. Res., 1996, 57, 220-223.
183. Morrison D.F., Foss D.L., Murtaugh M.P. Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia. Infect. Immun., 2000, 68, 4752-4758.
184. Narita M., Kawashima K., Morozumi T., Takashima H. Effect of physical defenses of the respiratory tract on the development of pneumonia in pigs inoculated endobronchially with Actinobacillus pleuropneumoniae. J. Vet. Med. Sci., 1995, 57, 839- 844.
185. Narita M., Kawashima K., Nakagawa H., Uchimura A., Ohashi T., Kimura K., Tanimura N. Immunohistopathological characterization of pig pneumonia caused by a combined Aujeszky's disease virus and Actinobacillus pleuropneumoniae infection. J. Comp. Pathol., 1997, 117, 25-33.
186. Nathan C. Nitric oxide as a secretory product of mammalian cells. Faseb. J., 1992, 6, 3051- 3064.
187. Nicolet J. [Haemophilus infection in pigs. 3. Serological studies on Haemophilus parahaemolyticus]. Zentralbl. Bakteriol., 1971, 216, 487-495.
188. Nicolet J. Actinobacillus pleuropneumoniae. In : Leman A.D., Straw B.E., Mengeling W.L., D'Allaire S., Taylor D.J. (Eds), Diseases of swine. 7th ed. Wolfe: London, 1992, 401-408.
189. Nielsen R. Haemophilus pleuropneumoniae serotypes: cross protection experiments. Nord. Vet. Med., 1984, 36, 221-234.
190. Nielsen R. Seroepidemiology of Actinobacillus pleuropneumoniae. Can. Vet. J., 1988, 29, 580-582.
191. Nielsen R., Van Den Bosch J.F., Plambeck T., Sorensen V., Nielsen J.P. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae. Vet. Microbiol., 2000, 71, 81-87.
192. Norcia L.J., Silvia A.M., Hayashi S.F. Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli. J. Antibiot., 1999, 52, 52-60.
193. Pabst R. The respiratory immune system of pigs. Vet. Immunol. Immunopathol., 1996, 54, 191-195.
194. Palacios-Arriaga J.M., Gutierrez-Pabello J.A., Chavez-Gris G., Hernandez-Castro R. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae. Rev. Latinoam. Microbiol., 2000, 42, 27-33.
195. Pampusch M.S., Bennaars A.M., Harsch S., Murtaugh M.P. Inducible nitric oxide synthase expression in porcine immune cells. Vet. Immunol. Immunopathol., 1998, 61, 279-289.
196. Paradis M.A., Vessie G.H., Merrill J.K., Dick C.P., Moore C., Charbonneau G., Gottschalk M., Macinnes J.I., Higgins R., Mittal K.R., Girard C., Aramini J.J., Wilson J.B. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine. Can. J. Vet. Res., 2004, 68, 7-11.
197. Perfumo C.J., Rehbinder C., Karlsson K. Swine pleuropneumonia produced by Haemophilus pleuropneumoniae. III. An electron microscopic study. Zentralbl. Veterinarmed. B, 1983, 30, 678-684.
198. Perry M.B., Altman E., Brisson J.R., Beynon L.M., Richards J.C. Structural characteristics of the antigen capsular polysaccharides and lipopolysaccharides involved in the serological classification of Actinobacillus (Haemophilus) pleuropneumoniae strains. Serodiagn. Immunother. Infect. Dis., 1990, 4, 299-308.
199. Phelps D.T., Ferro T.J., Higgins P.J., Shankar R., Parker D.M., Johnson A. TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am. J. Physiol., 1995, 269, L551-559.
200. Piffer I.A., Carter G.R., Botovchenco A.A. Identification of serotypes of Haemophilus pleuropneumoniae by counterimmunoelectrophoresis. Vet. Rec., 1986, 118, 292-294.
201. Pijoan C. Effect of Pasteurella multocida and Haemophilus pleuropneumoniae toxins on swine alveolar macrophages. Vet. Immunol. Immunopathol., 1986, 13, 141-149.
202. Plagemann P.G. Porcine reproductive and respiratory syndrome virus: origin hypothesis. Emerg. Infect. Dis., 2003, 9, 903-908.
203. Pol J.M., Van Leengoed L.A., Stockhofe N., Kok G., Wensvoort G. Dual infections of PRRSV/influenza or PRRSV/Actinobacillus pleuropneumoniae in the respiratory tract. Vet. Microbiol., 1997, 55, 259-264.
204. Prideaux C.T., Pierce L., Krywult J., Hodgson A.L. Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination. Curr. Microbiol., 1998, 37, 324-332.
205. Prideaux C.T., Lenghaus C., Krywult J., Hodgson A.L. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon. Infect. Immun., 1999, 67, 1962-1966.
206. Radacovici S., Gottschalk M., Dubreuil J.D. Lipopolysaccharides of Actinobacillus pleuropneumoniae (serotype 1): a readily obtainable antigen for ELISA serodiagnosis of pig pleuropneumonia. Vet. Microbiol., 1994, 39, 219-230.
207. Ramjeet M., Deslandes V., St Michael F., Cox A.D., Kobisch M., Gottschalk M., Jacques M. Truncation of the lipopolysaccharide outer core affects susceptibility to antimicrobial peptides and virulence of Actinobacillus pleuropneumoniae serotype 1. J. Biol. Chem., 2005, 280, 39104-39114.
208. Reiss M., Roos D. Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J. Clin. Invest., 1978, 61, 480-488.
209. Rennick D.M., Fort M.M., Davidson N.J. Studies with IL-10-/ -mice: an overview. J. Leukoc. Biol., 1997, 61, 389-396.
210. Rioux S., Dubreuil D., Begin C., Laferriere C., Martin D., Jacques M. Evaluation of protective efficacy of an Actinobacillus pleuropneumoniae serotype 1 lipopolysaccharide-protein conjugate in mice. Comp. Immunol. Microbiol. Infect. Dis., 1997, 20, 63-74.
211. Rioux S., Girard C., Dubreuil J.D., Jacques M. Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs. Res. Vet. Sci., 1998, 65, 165-167.
212. Rioux S., Galarneau C., Harel J., Kobisch M., Frey J., Gottschalk M., Jacques M. Isolation and characterization of a capsule-deficient mutant of Actinobacillus pleuropneumoniae serotype 1. Microb. Pathog., 2000, 28, 279-289.
213. Rodriguez Barbosa J.I., Gutierrez Martin C.B., Tascon R. I., Suarez J., Rodriguez Ferri E.F. Evidence obtained with monoclonal antibodies that O antigen is the major antigen responsible for the cross-reactivities between serotypes 4 and 7 of Actinobacillus (Haemophilus) pleuropneumoniae. Clin. Diagn. Lab. Immunol., 1995, 2, 563-568.
214. Rodriguez Barbosa J.I., Gutierrez Martin C.B., Tascon R.I., Gonzalez O.R., Mittal K.R., Rodriguez Ferri E.F. Characterization of monoclonal antibodies that recognize common epitopes located on O antigen of lipopolysaccharide of serotypes 1, 9 and 11 of Actinobacillus pleuropneumoniae. FEMS Immunol. Med. Microbiol., 1996, 16, 173-181.
215. Rogers R.J., Eaves L.E., Blackall P.J., Truman K.F. The comparative pathogenicity of four serovars of Actinobacillus (Haemophilus) pleuropneumoniae. Aust. Vet. J., 1990, 67, 9-12.
216. Rosendal S., Lombin L., Demoor J. Serotyping and detection of Haemophilus pleuropneumoniae by indirect fluorescent antibody technique. Can. J. Comp. Med., 1981, 45, 271-274.
217. Rosendal S., Mitchell W.R. Epidemiology of Haemophilus pleuropneumoniae infection in pigs: a survey of Ontario Pork Producers, 1981. Can. J. Comp. Med., 1983, 47, 1-5.
218. Rosendal S., Boyd D.A., Gilbride K.A. Comparative virulence of porcine Haemophilus bacteria. Can. J. Comp. Med., 1985, 49, 68-74.
219. Rosendal S., Macinnes J.I. Characterization of an attenuated strain of Actinobacillus pleuropneumoniae, serotype 1. Am. J. Vet. Res., 1990, 51, 711- 717.
220. Saito K., Sakpuaram T., Fukuyasu T., Ashida K. Serological heterogeneity of Actinobacillus (Haemophilus) pleuropneumoniae serotype 5 strains. J. Vet. Med. Sci., 1992, 54, 349-350.
221. Sakano T., Shibata I., Samegai Y., Taneda A., Okada M., Irisawa T., Sato S. Experimental pneumonia of pigs infected with Aujeszky's disease virus and Actinobacillus pleuropneumoniae. J. Vet. Med. Sci., 1993, 55, 575-579.
222. Salmon S.A., Watts J.L., Yancey R.J., JR. In vitro activity of ceftiofur and its primary metabolite, desfuroylceftiofur, against organisms of veterinary importance. J. Vet. Diagn. Invest., 1996, 8, 332-336.
223. Salvemini D., Manning P.T., Zweifel B.S., Seibert K., Connor J., Currie M.G., Needleman P., Masferrer J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J. Clin. Invest., 1995, 96, 301-308.
224. Sanford S.E., Josephson G.K. Porcine Haemophilus pleuropneumonia epizootic in southwestern Ontario: clinical, microbiological, pathological and some epidemiological findings. Can. J. Comp. Med., 1981, 45, 2-7.
225. Satran P., Nedbalcova K. Prevalence of serotypes, production of Apx toxins, and antibiotic resistance in strains of Actinobacillus pleuropneumoniae isolated in the Czech Republic. Vet. Med., 2002, 47, 92-98.
226. Scamurra R., Arriaga C., Sprunger L., Baarsch M.J., Murtaugh M.P. Regulation of interleukin-6 expression in porcine immune cells. J. Interferon Cytokine Res., 1996, 16, 289-296.
227. Schaller A., Kuhn R., Kuhnert P., Nicolet J., Anderson T.J., Macinnes J.I., Segers R.P., Frey J. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology, 1999, 145, 2105-2116.
228. Schaller A., Kuhnert P., De La Puente-Redondo V.A., Nicolet J., Frey J. Apx toxins in Pasteurellaceae species from animals. Vet. Microbiol., 2000, 74, 365-376.
229. Schaller A., Djordjevic S.P., Eamens G.J., Forbes W.A., Kuhn R., Kuhnert P., Gottschalk M., Nicolet J., Frey J. Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apxIVA. Vet. Microbiol., 2001, 79, 47-62.
230. Schimmel D., Hass R. [Serotyping of Haemophilus pleuropneumoniae strains]. Arch. Exp. Veterinarmed., 1983, 37, 549-551.
231. Schuchert J.A., Inzana T.J., Angen O., Jessing S. Detection and identification of Actinobacillus pleuropneumoniae serotypes 1, 2, and 8 by multiplex PCR. J. Clin. Microbiol., 2004, 42, 4344-4348.
232. Sebunya T.N., Saunders J.R. Haemophilus pleuropneumoniae infection in swine: a review. J. Am. Vet. Med. Assoc., 1983, 182, 1331-1337.
233. Sebunya T.N., Saunders J.R., Osborne A.D. Dose response relationship of Haemophilus pleuropneumoniae aerosols in pigs. Can. J. Comp. Med., 1983, 47, 54-56.
234. Serebrin S., Rosendal S., Valdivieso-Garcia A., Little P.B. Endothelial cytotoxicity of Actinobacillus pleuropneumoniae. Res. Vet. Sci., 1991, 50, 18-22.
235. Shin S.J., Kang S.G., Nabin R., Kang M.L., Yoo H.S. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Vet. Microbiol., 2005a, 106, 73-77.
236. Shin S.J., Bae J.L., Cho Y.W., Lee D.Y., Kim D.H., Yang M.S., Jang Y.S., Yoo H.S. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobaci llus pleuropneumoniae ApxIIA. FEMS Immunol. Med. Microbiol., 2005b, 43, 155-164.
237. Shryock T.R., Staples J.M., Derosa D.C. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease. J. Vet. Diagn. Invest., 2002, 14, 389-395.
238. Sibille Y., Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis., 1990, 141, 471-501.
239. Sidibe M., Messier S., Lariviere S., Gottschalk M., Mittal K.R. Detection of Actinobacillus pleuropneumoniae in the porcine upper respiratory tract as a complement to serological tests. Can. J. Vet. Res., 1993, 57, 204-208.
240. Spits H., De Waal Malefyt R. Functional characterization of human IL-10. Int. Arch. Allergy Immunol., 1992, 99, 8-15.
241. Stark K.D., Miserez R., Siegmann S., Ochs H., Infanger P., Schmidt J. A successful national control programme for enzootic respiratory diseases in pigs in Switzerland. Rev. Sci. Tech., 2007, 26, 595-606.
242. Stenbaek E.I., Schirmer A.L. Detection of Actinobacillus pleuropneumoniae serotype 2 antibodies in pig sera by an inhibition enzyme immuno assay (EIA). Vet. Microbiol., 1994, 39, 231-244.
243. Stenbaek E.I., Hovindhaugen K. Detection of an Actinobacillus pleuropneumoniae serotype 2 lipopolysaccharide (LPS) variant. Vet. Microbiol., 1996, 52, 285-292.
244. Stephens K.E., Ishizaka A., Wu Z.H., Larrick J.W., Raffin T.A. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am. Rev. Respir. Dis., 1988, 138, 1300-1307.
245. Sthitmatee N., Sirinarumitr T., Makonkewkeyoon L., Sakpuaram T., Tesaprateep T. Identification of the Actinobacillus pleuropneumoniae serotype using PCR based-apx genes. Mol. Cell Probes, 2003, 17, 301-305.
246. Stine D.L., Huether M.J., Moxley R.A., Srikumaran S. Actinobacillus pleuropneumoniae- induced thymic lesions in mice and pigs. Infect. Immun., 1991, 59, 2885-2891.
247. Stipkovits L., Miller D., Glavits R., Fodor L., Burch D. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Can. J. Vet. Res., 2001, 65, 213-222.
248. Tanigawa M., Sawada T. Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae. J. Vet. Med. B Infect. Dis. Vet. Public Health, 2002, 49, 513-518.
249. Tarasiuk K., Pejsak Z., Hogg A., Carlson M.P. Efficacy of an Actinobacillus pleuropneumoniae bacterin against serotypes 1, 3, 5 and 9. Can. Vet. J., 1994, 35, 233-238.
250. Tarigan S., Slocombe R.F., Browning G.F., Kimpton W. Functional and structural changes of porcine alveolar macrophages induced by sublytic doses of a heat-labile, hemolytic, cytotoxic substance produced by Actinobacillus pleuropneumoniae. Am. J. Vet. Res., 1994, 55, 1548-1557.
251. th ed. Blackwell : London, 1999, 343-354.
252. Thomassen M.J., Divis L.T., Fisher C.J. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clin. Immunol. Immunopathol., 1996, 80, 321-324.
253. Tonpitak W., Baltes N., Hennig-Pauka I., Gerlach G.F. Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine. Infect. Immun., 2002, 70, 7120-7125.
254. Torremorell M., Pijoan C., Janni K., Walker R., Joo H.S. Airborne transmission of Actinobacillus pleuropneumoniae and porcine reproductive and respiratory syndrome virus in nursery pigs. Am. J. Vet. Res., 1997, 58, 828-832.
255. Tumamao J.Q., Bowles R.E., Van Den Bosch H., Klaasen H.L., Fenwick B.W., Blackall P.J. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomyc-independent pleuropneumonia vaccines. Aust. Vet. J., 2004a, 82, 773-780.
256. Tumamao J.Q., Bowles R.E., Van Den Bosch H., Klaasen H.L., Fenwick B.W., Storie G.J., Blackall P.J. Comparison of the efficacy of a subunit and a live streptomycin-dependent porcine pleuropneumonia vaccine. Aust. Vet. J., 2004b, 82, 370-374.
257. Turni C., Blackall P.J. An evaluation of the apxIVA based PCR-REA method for differentiation of Actinobacillus pleuropneumoniae. Vet. Microbiol., 2007, 121, 163-169.
258. Udeze F.A., Latimer K.S., Kadis S. Role of Haemophilus pleuropneumoniae lipopolysaccharide endotoxin in the pathogenesis of porcine Haemophilus pleuropneumonia. Am. J. Vet. Res., 1987, 48, 768-773.
259. Ueda Y., Suenaga I. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae. J. Vet. Med. Sci., 1995, 57, 363-364.
260. Ueda Y., Ohtsuki S., Narukawa N. Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs. J. Vet. Med. Sci., 1995, 57, 261-265.
261. Van de Kerkhof A., Haesebrouck F., Chiers K., Ducatelle R., Kamp E.M., Smits M.A. Influence of Actinobacillus pleuropneumoniae and its metabolites on porcine alveolar epithelial cells. Infect. Immun., 1996, 64, 3905-3907.
262. Van Den Bosch H., Frey J. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs. Vaccine, 2003, 21, 3601-3607.
263. Van Leengoed L.A., Kamp E.M. Endobronchial inoculation of various doses of Haemophilus (Actinobacillus) pleuropneumoniae in pigs. Am. J. Vet. Res., 1989, 50, 2054-2059.
264. Van Leengoed L.A., Kamp E.M., Pol J.M. Toxicity of Haemophilus pleuropneumoniae to porcine lung macrophages. Vet. Microbiol., 1989, 19, 337-349.
265. Van Ostaaijen J., Frey J., Rosendal S., Macinnes J.I. Actinobacillus suis strains isolated from healthy and diseased swine are clonal and carry apxICABDvar. suis and apxIICAvar. suis toxin genes. J. Clin. Microbiol., 1997, 35, 1131-1137.
266. Van Overbeke I., Chiers K., Ducatelle R., Haesebrouck F. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins. J. Vet. Med. B Infect. Dis. Vet. Public Health, 2001, 48, 15-20.
267. Van Overbeke I., Chiers K., Charlier G., Vandenberghe I., Van Beeumen J., Ducatelle R., Haesebrouck F. Characterization of the in vitro adhesion of Actinobacillus pleuropneumoniae to swine alveolar epithelial cells. Vet. Microbiol., 2002, 88, 59-74.
268. Van Overbeke I., Chiers K., Donne E., Ducatelle R., Haesebrouck F. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions. J. Vet. Med. B Infect. Dis. Vet. Public Health, 2003, 50, 289-293.
269. Velthuis A.G., De Jong M.C., Kamp E.M., Stockhofe N., Verheijden J.H. Design and analysis of an Actinobacillus pleuropneumoniae transmission experiment. Prev. Vet. Med., 2003, 60, 53-68.
270. Vigre H., Ersboll A.K., Sorensen V. Decay of acquired colostral antibodies to Actinobacillus pleuropneumoniae in pigs. J. Vet. Med. B Infect. Dis. Vet. Public Health, 2003, 50, 430-435.
271. Wallgren P., Segall T., Pedersen Morner A., Gunnarsson A. Experimental infections with Actinobacillus pleuropneumoniae in pigs-II. Comparison of antibiotics for oral strategic treatment. Zentralbl. Veterinarmed. B, 1999a, 46, 261-269.
272. Wallgren P., Segall T., Pedersen Morner A., Gunnarsson A. Experimental infections with Actinobacillus pleuropneumoniae in pigs-I. Comparison of f ive different parenteral antibiotic treatments. Zentralbl. Veterinarmed. B, 1999b, 46, 249-260.
273. Wang C., Liu S., Peng Y., Shao M., Wang Y., Gong Q., Chang Y., Liu J., Liu H., Liu D., Kong X. Renaturation and purification of ApxII toxin of Actinobacillus pleuropneumoniae. Protein Expr. Purif., 2007, 52, 441-445.
274. Ward C.K., Lawrence M.L., Veit H.P., Inzana T.J. Cloning and mutagenesis of a serotyp-especific DNA region involved in encapsulation and virulence of Actinobacillus pleuropneumoniae serotype 5a: concomitant expression of serotype 5a and 1 capsular polysaccharides in recombinant A. pleuropneumoniae serotype 1. Infect. Immun., 1998, 66, 3326-3336.
275. Wasteson Y., Roe D.E., Falk K., Roberts M.C. Characterization of tetracycline and erythromycin resistance in Actinobacillus pleuropneumoniae. Vet. Microbiol., 1996, 48, 41-50.
276. Westfall J.A., Chatterjee A., Anderson N.V. Actinobacillus pleuropneumoniae in gnotobiotic piglets: ultrastructural changes in the pulmonary alveoli with dose and time. J. Submicrosc. Cytol. Pathol., 1994, 26, 41-50.
277. Xu F., Chen X., Shi A., Yang B., Wang J., Li Y., Guo X., Blackall P.J., Yang H. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae. Vet. Microbiol., 2006, 118, 230-239.
278. Yan K.X., Liu J.J., Zhou R., Wu B., Liu W.H., Chen H.C. [Acute toxicity and immunoprotection of recombinant ApxI toxin of Actinobacillus pleuropneumoniae in mice]. Sheng Wu Gong Cheng Xue Bao, 2006, 22, 65-70.
279. Yoshimura H., Takagi M., Ishimura M., Endoh Y.S. Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae. Vet. Res. Commun., 2002, 26, 11-19.
280. Young T.F., Ross R.F., Drisko J. Prevalence of antibodies to Mycoplasma hyopneumoniae in Iowa swine. Am. J. Vet. Res., 1983, 44, 1946-1948.
281. Zingarelli B., O'Connor M., Wong H., Salzman A.L., Szabo C. Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol., 1996, 156, 350-358.